The Alcatel-Lucent TeleHealth Manager supports remote affected person monitoring with an easily deployable solution for standard mobile phones from leading suppliers. It allows patients to supply health data using gadgets they’re already acquainted with in a secure manner, without the expense, time and potential contact with other diseases that unneeded clinical visits might entail. In addition to monitoring, TeleHealth Manager provides reminders, alerts and online reports to help individuals and their healthcare professionals better understand and manage their conditions. Related StoriesHealthcare technology sociable event of the year opens entriesUsing integrated molecular pathology to control incidental pancreatic cysts: an interview with Dr Ananya DasSurgical startup seeks financing to build digital reality schooling libraryFaced with issues such as an aging populace and rising health care costs, hospitals and physicians are increasingly embracing innovative communications systems such as remote patient monitoring to supplement face-to-face care.With this success we believe we have an approvable product, and Stage 3 preparatory actions for RoclatanTM are commencing instantly. The entire Aerie team remains focused on continue towards Phase 3 sign up trials for RoclatanTM, and initiating the Phase 3 sign up trials for our various other innovative product, triple-actions RhopressaTM,’ stated Vicente Anido, Jr., Ph.D., Chief and Chairman Executive Officer at Aerie. With regard to commercialization potential, Dr. Anido added, ‘With these strong data, we are a lot more confident that our products have blockbuster potential. We continue to expect to market our items through our own sales force in North America, and intend to commence licensing discussions for commercialization outside of THE UNITED STATES.’ Richard L.